RxDoctor Payments Data

Brenda Acosta Ashby

Endocrinology, Diabetes & Metabolism · Doral, FLNPI 1366480386

Payments from drug & device makers

$116,834in general payments, 2019–2025

Across 223 payments — averaging $523.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$62K
  • Sanofi-aventis U.S. LLC$29K
  • Merck$19K
  • Lilly USA, LLC$3K
  • Boehringer Ingelheim$2K
  • Johnson & Johnson$811
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$2,9253%
  • Speaking & faculty fees$102,52688%
  • Travel & lodging$5,2384%
  • Food & beverage$6,1145%
  • Education$310%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$116,834 in reported general payments places this provider in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metformin Hcl14$86

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Doral

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →